Description
Comprehensive coverage of the IVD Market including the Worldwide Market Report (11th edition) and the 2019 IVD Market Trends Summary
Bundle and save 20% over buying these reports individually!
The Worldwide Market for In Vitro Diagnostic (IVD) Tests, 11th Edition
This Kalorama Information report represents the 11th edition of this comprehensive look at the IVD industry. At 1,800 pages report provides market size estimates and projections for the entirety of the clinical diagnostics testing market. It also profiles hundreds of competitors, notes significant acquisitions and other deals, discusses trends and breaks out regional and country markets. The report provides market size and forecasts to 2023 for defined segments of the IVD market and various sub-segments. The 1,800-page report provides in vitro diagnostics market size estimates and projections for the entirety of the in vitro diagnostics testing market.
Current 2018 IVD Market Estimates For Essential Segments
The Worldwide Market for In Vitro Diagnostic (IVD) Tests estimates the current in vitro diagnostics market size and forecasted market size to 2023 for defined segments of the IVD market and various sub-segments, including:
• Molecular Assays (Infectious Disease, Blood Screening, Inherited Diseases, Oncology, Pharmacodiagnostics, Tissue Typing, Prenatal)
• Clinical Chemistry and “Core Lab” Markets (including sub segment revenues for General Chemistries, Workstations, Analyzers Blood Gases, Urinalysis, Critical Care)
• Point-of-Care Testing (POC), (Professional and Self-Testing, Glucose Testing, Pregnancy Tests, drugs of abuse, HIV, H. pylori, Other, OTC/Self Total, Professional POC, Cardiac Markers, Drugs of Abuse, HbA1c, Pregnancy, Other)
• Substance Abuse Testing
• Microbiology and Virology by Test Type (Immunoassays, ID/AST, Infectious Diseases – DNA; ID/AST: Panels and Reagents, automated; Panels and Reagents, manual; Blood Culture; Chromogenic Media; Rapid Micro; Supplies)
• Blood Banking (Grouping, Immunoassay Screens, NAT Screens)
• Tissue-Based Testing – Histology and Cytology (Pap, ISH, IHC, HPV)
• Infectious Disease Immunoassay Testing (Hepatitis, HIV, STDs, TORCH, Respiratory, Sepsis, Parasitology, Mycology, Others)
• Hematology
• Flow Cytometry
• Molecular Tests in Infectious Diseases (HAI, HIV, Hepatitis, GC/Chlamydia, Respiratory, Organism ID, Mycobacteria, TB, Others)
• Non-Infectious Disease Immunoassay Sales by Analyte Type (Cardiac markers, Tumor markers, Diabetes/HbA1c, Autoimmune, Allergy, Thyroid, Proteins, Anemia, Fertility, Therapeutic drugs, Tox/Drugs of abuse, Vitamin D)
• Coagulation Tests (Lab-Based, POC, Genetic Markers)
• Mass Spectrometry
• Molecular Point-Of-Care
• Next Generation Sequencing
• Direct-to-Consumer Testing
The report also tracks hundreds of competitors, notes significant partnerships, distribution deals and acquisitions and defines the market share situation for the in vitro diagnostic market and competitive analysis for many segments.
To learn more, visit: https://kaloramainformation.com/product/the-worldwide-market-for-in-vitro-diagnostic-ivd-tests-11th-edition/
IVD Market Trends Summary
In vitro diagnostic (IVD) products continue to see positive sales growth in many categories, while others mature. New products, changes in global health spending, regulatory changes in major markets and disease trends are among the factors that produce a constantly changing market picture. IVD Market Trends Summary features current trends and updates in the worldwide IVD market. Highlights of these updates include:
- Market developments in developing markets – Latin America, the Middle East and Eastern Europe
- Effects of PAMA in the US IVD market
- Effects of US tariffs on the Chinese IVD market
- Molecular point-of-care market
- New products receiving with either FDA 510(k) clearance, CLIA waiver or CE marking
- New developments in tick-borne disease testing
- Babesiosis testing
- Development of a point-of-care concussion testing/brain trauma
- Importance of flu testing – development in over-the-counter (OTC) flu tests
- Infectious diseases testing – Zika, Ebola and Chagas
To learn more, visit: https://kaloramainformation.com/product/ivd-market-trends-summary/
